Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2012 | 09-2011 | 09-2010 | |
| Sales | 36,565 | 0 | 0 |
| Gross Profit | 36,565 | N/A | N/A |
| Operating Expenses | 4,470 | 0 | 0 |
| Operating Income | 32,095 | N/A | N/A |
| Other Income | 16 | 0 | 0 |
| Pre-tax Income | 32,111 | 0 | 0 |
| Net Income Continuous | 32,111 | N/A | N/A |
| Net Income | $32,111 | $N/A | $N/A |
| EPS Basic Total Ops | 2.41 | N/A | N/A |
| EPS Basic Continuous Ops | 29.51 | N/A | N/A |
| EPS Diluted Total Ops | 2.17 | N/A | N/A |
| EPS Diluted Continuous Ops | 12.66 | N/A | N/A |
| EBITDA(a) | $32,095 | $N/A | $N/A |